Charles Grob

When the individual is told that he or she has a limited life expectancy,
it is very common to have a great deal of anxiety about the anticipated
pain that might occur and anxiety about the unknown.
What does the passage to death signify? – Charles Grob

Charles Grob

Charles Grob MD is professor of Psychiatry and Pediatrics at the UCLA School of Medicine and Director of the Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center.

Alongside Dennis Mckenna, he is also a founding board member and Director of Clinical Research for The Heffter Institute, a non-profit organization dedicated to the scientific study of psychedelics. In 1994, Charles launched the first government-approved study of MDMA, evaluating safe dosage, potential neurotoxicity from large doses and possible long-term impacts on neuroplasticity.

He led an international team of experts looking into the long-term effects of ayahuasca use by Brazilian members of the União do Vegetal church, finding beneficial effects on those with substance addiction problems. The team also found that platelet serotonin uptake sites increased in those who drank ayahuasca, which may have implications related to potential antidepressant effects of this visionary brew.

Charles is currently conducting an investigation of the effects of psilocybin on anxiety in cancer patients, has published numerous articles in medical and psychiatric journals and is the editor of Hallucinogens: A Reader.

Charles Grob's films

Follow
Charles Grob

Newsletter

Want to hear about fascinating people such as this one?
Get our monthly, 100% spam free, newsletter

Sign off any time. No spam. Ever. We promise.

This is a unique website which will require a more modern browser to work!

Please upgrade today!